Abstract
Multiple myeloma (MM) is a malignant hematologic cancer characterized by infiltration of plasma tumor cells into the bone marrow (BM), synthesis and secretion of clonal immunoglobulins and tissue damage such as bone lesions, hypercalcemia, anemia and renal failure. Despite progress in treatment, the MM remains incurable due to high rate of relapse. The presence of cancer stem cells (CSCs)…